DNA — GINKGO BIOWORKS HOLDINGS INC

Ownership history in FINANCIAL CONSULATE, INC  ·  6 quarters on record

This page tracks every 13F SEC filing in which FINANCIAL CONSULATE, INC reported a position in GINKGO BIOWORKS HOLDINGS INC (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2022 Q1)
Avg. % of fund
0.01%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 250 -9,750 -97.5% 0.00% $4K $14.58
2023 Q1 UNCHANGED 10,000 — 0% 0.00% $13K $53.20
2022 Q4 UNCHANGED 10,000 — 0% 0.01% $17K $67.60
2022 Q3 UNCHANGED 10,000 — 0% 0.01% $31K $124.80
2022 Q2 UNCHANGED 10,000 — 0% 0.01% $24K $95.20
2022 Q1 INITIATED 10,000 — — 0.02% $40K $161.20
% of Fund (quarterly)    DNA price (monthly, adj. close)

Other funds also holding DNA

As of 2025 Q4 — sorted by position size

Anchorage Capital Group, L.L.C. 3Y 7Y 16.39% Madrona Venture Group, LLC 3Y 1.6% FORBES J M & CO LLP 3Y 7Y 0.7% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.42% Coastal Bridge Advisors, LLC 3Y 7Y 0.17% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.14% Erste Asset Management GmbH 0.14% Green Alpha Advisors, LLC 3Y 0.11% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.08% ALLEN OPERATIONS LLC 3Y 7Y 0.06%
← Back to FINANCIAL CONSULATE, INC Holdings